Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients

Thromb Haemost. 2009 May;101(5):802-5.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / mortality
  • Female
  • Healthcare Disparities
  • Hemorrhage / chemically induced
  • Hemorrhage / mortality
  • Humans
  • Male
  • Quality of Health Care
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Stroke / etiology
  • Stroke / mortality
  • Stroke / prevention & control*
  • Thromboembolism / etiology
  • Thromboembolism / mortality
  • Thromboembolism / prevention & control*
  • Time Factors
  • Treatment Outcome
  • Warfarin / administration & dosage*
  • Warfarin / adverse effects
  • Women's Health*

Substances

  • Anticoagulants
  • Warfarin